Bioton S.A.
Develops and manufactures recombinant human insulin for global diabetes care solutions.
BIO | WAR
Overview
Corporate Details
- ISIN(s):
- PLBIOTN00029
- LEI:
- 259400I5R1L3OPCGII81
- Country:
- Poland
- Address:
- Warszawa Starościńska 5, 02-516 Warszawa
- Website:
- https://bioton.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Bioton S.A. is an innovative biotechnology company specializing in providing comprehensive solutions for diabetes care. The company's core activities include the research, development, manufacturing, and commercialization of pharmaceutical products, with a primary focus on recombinant human insulin. Bioton manages the entire drug production process, from advanced R&D and the synthesis of active pharmaceutical ingredients to the distribution of finished medicinal products. Recognized as a leader in the Polish market, the company is also one of the top commercial manufacturers of recombinant human insulin globally, operating from its modern production facility near Warsaw.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-08 17:44 |
Sprawozdanie Rady Nadzorczej Bioton S.A. za 2023
|
Polish | 383.7 KB | ||
| 2024-05-08 17:44 |
Sprawozdanie Rady Nadzorczej BIOTON S.A. o wynagrodzeniach
|
Polish | 363.7 KB | ||
| 2024-05-08 17:44 |
Raport z oceny sprawozdania o wynagrodzeniach
|
Polish | 248.3 KB | ||
| 2024-05-08 17:44 |
Ogłoszenie ZWZ
|
Polish | 358.7 KB | ||
| 2024-05-08 17:44 |
Zwołanie Zwyczajnego Walnego Zgromadzenia BIOTON S.A. - Content (PL)
|
Polish | 850 bytes | ||
| 2024-05-08 17:28 |
Ocena Rady Nadzorczej do sprawozdań finansowych
|
Polish | 191.8 KB | ||
| 2024-05-08 17:28 |
Korekta raportu okresowego oraz skonsolidowanego raportu okresowego za rok 2023…
|
Polish | 859 bytes | ||
| 2024-04-26 19:40 |
Zmiana terminu publikacji skonsolidowanego "rozszerzonego" raportu kwartalnego …
|
Polish | 788 bytes | ||
| 2024-03-28 18:30 |
Sprawozdanie z badania SSF
|
Polish | 10.2 KB | ||
| 2024-03-28 18:30 |
Sprawozdanie z badania SSF
|
Polish | 2.8 MB | ||
| 2024-03-28 18:30 |
Oświadczenie Rady Nadzorczej - Komitet Audytu
|
Polish | 619.1 KB | ||
| 2024-03-28 18:30 |
Informacja Zarządu - wybór firmy audytorskiej
|
Polish | 17.0 KB | ||
| 2024-03-28 18:30 |
Informacja Zarządu - wybór firmy audytorskiej
|
Polish | 698.6 KB | ||
| 2024-03-28 18:30 |
Sprawozdanie Zarządu z działalności
|
Polish | 16.9 KB | ||
| 2024-03-28 18:30 |
Sprawozdanie Zarządu z działalności
|
Polish | 7.1 MB |
Automate Your Workflow. Get a real-time feed of all Bioton S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Bioton S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Bioton S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
